EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evolutionary Origin of Human PALB2 Germline Pathogenic Variants

Jia Sheng Chian, Jiaheng Li, San Ming Wang iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jia Sheng Chian und 2 weiteren Autor:innen. Beteiligte Einrichtung: MoE Frontiers Science Center for Precision Oncology, Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of…. Hauptthemen laut MEDLINE: Breast Neoplasms, Fanconi Anemia Complementation Group N Protein, Germ-Line Mutation, Ovarian Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Macau Science and Technology Development Fund, the University of Macau, the Faculty of Health Sciences, University of Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PALB2 (Partner and localizer of BRCA2) is crucial for repairing DNA double-stranded breaks (DSBs) through homologous recombination (HR). Germline pathogenic variation in PALB2 disrupts DNA damage repair and increases the risk of Fanconi Anemia, breast cancer, and ovarian cancer. Determination of the evolutionary origin of human PALB2 variants will promote a deeper understanding of the biological basis of PALB2 germline variation and its roles in human diseases. We tested the evolution origin for 1444 human PALB2 germline variants, including 484 pathogenic and 960 benign variants. We performed a phylogenic analysis by tracing the variants in 100 vertebrates. However, we found no evidence to show that cross-species conservation was the origin of PALB2 germline pathogenic variants, but it is indeed a rich source for PALB2 germline benign variants. We performed a paleoanthropological analysis by tracing the variants in over 5000 ancient humans. We identified 50 pathogenic in 71 ancient humans dated from 32,895 to 689 before the present, of which 90.1% were dated within the recent 10,000 years. PALB2 benign variants were also highly shared with ancient humans. Data from our study reveal that human PALB2 pathogenic variants mostly arose in recent human history.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFanconi Anemia Complementation Group N ProteinGerm-Line MutationOvarian NeoplasmsFanconi AnemiaAnimalsFemaleHumansBRCA2 ProteinDNA RepairGenetic Predisposition to DiseaseGerm CellsEvolution, Molecular

Stichwörter der Autor:innen

PALB2evolutionary originpaleoanthropologyphylogenetic

Substanzen

BRCA2 ProteinFanconi Anemia Complementation Group N ProteinPALB2 protein, human

Autor:innen und Institutionen

  • MoE Frontiers Science Center for Precision Oncology, Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao.

ORCID-Profile: San Ming Wang

Förderung

  • the Macau Science and Technology Development Fund
  • the University of Macau
  • the Faculty of Health Sciences, University of Macau

Zitieren

APA

Chian, J. S., Li, J., & Wang, S. M. (2023). Evolutionary Origin of Human PALB2 Germline Pathogenic Variants. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411343

Vancouver

Chian JS, Li J, Wang SM. Evolutionary Origin of Human PALB2 Germline Pathogenic Variants. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411343

BibTeX
@article{Chian2023,
  author = {Chian, Jia Sheng and Li, Jiaheng and Wang, San Ming},
  title = {Evolutionary Origin of Human PALB2 Germline Pathogenic Variants},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411343}
}
Kostenlos starten →